We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nu Skin (NUS) Q1 Earnings Beat, Sales Miss, View Intact
Read MoreHide Full Article
After reporting negative earnings surprise of 1.3% in the fourth quarter of 2016, Nu Skin Enterprises, Inc. (NUS - Free Report) delivered positive earnings surprise in the first quarter of 2017. The company posted adjusted earnings of 51 cents per share that outpaced the Zacks Consensus Estimate of 49 cents and improved 21.4% from 42 cents earned in the prior-year quarter.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
On excluding the Japan customs charge, the earnings per share grew 21% year over year to 51 cents.
Despite earnings beat, Nu Skin’s shares declined 3.8% during the after-market trading hours, as investors remained skeptical about the company’s top-line performance that fell short of expectations for the second straight quarter. Nevertheless, we note that this Zacks Rank #2 (Buy) stock surged 49.1% over the past one year against the Zacks categorized Cosmetics & Toiletries industry’s loss of 20%.
Quarter in Detail
Revenues of $499.1 million in the first quarter rose 5.8% year over year but came below the Zacks Consensus Estimate of $503.3 million. The upside was driven by solid sales of the ageLOC Me and ageLOC Youth products coupled with social selling endeavors. In addition, results gained from robust growth witnessed at the Mainland China, South Asia/Pacific and EMEA regions. On a constant-currency basis, revenues increased 6.6% from the prior-year quarter.
The company’s sales leaders recorded a year-over-year decline of 1% to 54,600, its customers increased 2% to 9,80,000 from the prior-year quarter.
Region wise, revenues witnessed growth of 26.4% to $150 million in Mainland China, 9.8% to $69.8 million in South Asia/Pacific and 4.5% to $34.1 million in EMEA. However, revenues declined 4.2% to $82.5 million in South Korea, 0.1% to $65.7 million in Americas, 6% to $61.2 million in Japan and 10.3% to $35.9 million in Hong Kong/Taiwan.
On a constant-currency basis, revenues grew 33.1% in Mainland China, 11% in South Asia/Pacific and 6.6% in EMEA. However, the same fell 8.2% in South Korea, 0.4% in Americas, 7.3% in Japan and 13.4% in Hong Kong/Taiwan.
The company's adjusted gross profit grew 6.2% to $387.8 million in the quarter. Also, gross margin inflated 30 basis points (bps) to 77.7%.
Further, adjusted operating income jumped 17.2% to $46.3 million and operating margin expanded 90 bps to 9.3% in the quarter.
Other Financial Details
Nu Skin ended the quarter with cash and cash equivalents of $335.6 million, and total liabilities and stockholders' equity of $1,494.4 million.
During the quarter, the company repurchased shares worth $6.8 million, with an outstanding authorization of $192.9 million.
Additionally, it paid $19 million as dividends in the quarter. Concurrent to the earnings release, management declared a quarterly dividend of 36 cents a share payable on Jun 14 to shareholders of record as on May 26.
Guidance
Management remains impressed with its quarterly performance. Moving ahead, the company remains focused on innovations, programs as well as boosting its customers and sales leaders. Nu Skin also plans to launch its ageLOC LumiSpa product in the fourth quarter that is expected to generate roughly $100 million in revenues.
Nu Skin reiterated its guidance for 2017. Management continues to expect revenues of $2.26–$2.30 billion with an unfavorable currency impact of roughly 2–3%. Furthermore, earnings per share for 2017 are projected in the band of $3.10–$3.25. The Zacks Consensus Estimate for 2017 is currently pegged at $3.10.
For the second quarter, revenues are anticipated in the range of $530–$550 million including a negative currency impact of 1–2%. Moreover, earnings are estimated in the band of 65–70 cents per share. The Zacks Consensus Estimate is currently pegged higher at 85 cents.
Inter Parfums increased 22% over the past one year. Further, it posted an average earnings beat of 7.4% in the trailing four quarters.
Blue Buffalo Pet Products has a long-term earnings growth rate of 17.5%. Moreover, it posted an average earnings beat of 6.8% in the trailing four quarters.
Energizer, with a long-term earnings growth rate of 9.8% has surged 29.9% in the past one year.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
Image: Bigstock
Nu Skin (NUS) Q1 Earnings Beat, Sales Miss, View Intact
After reporting negative earnings surprise of 1.3% in the fourth quarter of 2016, Nu Skin Enterprises, Inc. (NUS - Free Report) delivered positive earnings surprise in the first quarter of 2017. The company posted adjusted earnings of 51 cents per share that outpaced the Zacks Consensus Estimate of 49 cents and improved 21.4% from 42 cents earned in the prior-year quarter.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise | Nu Skin Enterprises, Inc. Quote
On excluding the Japan customs charge, the earnings per share grew 21% year over year to 51 cents.
Despite earnings beat, Nu Skin’s shares declined 3.8% during the after-market trading hours, as investors remained skeptical about the company’s top-line performance that fell short of expectations for the second straight quarter. Nevertheless, we note that this Zacks Rank #2 (Buy) stock surged 49.1% over the past one year against the Zacks categorized Cosmetics & Toiletries industry’s loss of 20%.
Quarter in Detail
Revenues of $499.1 million in the first quarter rose 5.8% year over year but came below the Zacks Consensus Estimate of $503.3 million. The upside was driven by solid sales of the ageLOC Me and ageLOC Youth products coupled with social selling endeavors. In addition, results gained from robust growth witnessed at the Mainland China, South Asia/Pacific and EMEA regions. On a constant-currency basis, revenues increased 6.6% from the prior-year quarter.
The company’s sales leaders recorded a year-over-year decline of 1% to 54,600, its customers increased 2% to 9,80,000 from the prior-year quarter.
Region wise, revenues witnessed growth of 26.4% to $150 million in Mainland China, 9.8% to $69.8 million in South Asia/Pacific and 4.5% to $34.1 million in EMEA. However, revenues declined 4.2% to $82.5 million in South Korea, 0.1% to $65.7 million in Americas, 6% to $61.2 million in Japan and 10.3% to $35.9 million in Hong Kong/Taiwan.
On a constant-currency basis, revenues grew 33.1% in Mainland China, 11% in South Asia/Pacific and 6.6% in EMEA. However, the same fell 8.2% in South Korea, 0.4% in Americas, 7.3% in Japan and 13.4% in Hong Kong/Taiwan.
The company's adjusted gross profit grew 6.2% to $387.8 million in the quarter. Also, gross margin inflated 30 basis points (bps) to 77.7%.
Further, adjusted operating income jumped 17.2% to $46.3 million and operating margin expanded 90 bps to 9.3% in the quarter.
Other Financial Details
Nu Skin ended the quarter with cash and cash equivalents of $335.6 million, and total liabilities and stockholders' equity of $1,494.4 million.
During the quarter, the company repurchased shares worth $6.8 million, with an outstanding authorization of $192.9 million.
Additionally, it paid $19 million as dividends in the quarter. Concurrent to the earnings release, management declared a quarterly dividend of 36 cents a share payable on Jun 14 to shareholders of record as on May 26.
Guidance
Management remains impressed with its quarterly performance. Moving ahead, the company remains focused on innovations, programs as well as boosting its customers and sales leaders. Nu Skin also plans to launch its ageLOC LumiSpa product in the fourth quarter that is expected to generate roughly $100 million in revenues.
Nu Skin reiterated its guidance for 2017. Management continues to expect revenues of $2.26–$2.30 billion with an unfavorable currency impact of roughly 2–3%. Furthermore, earnings per share for 2017 are projected in the band of $3.10–$3.25. The Zacks Consensus Estimate for 2017 is currently pegged at $3.10.
For the second quarter, revenues are anticipated in the range of $530–$550 million including a negative currency impact of 1–2%. Moreover, earnings are estimated in the band of 65–70 cents per share. The Zacks Consensus Estimate is currently pegged higher at 85 cents.
Stocks You May Consider
Other stocks worth considering in the broader Consumer Staples sector include Inter Parfums, Inc. (IPAR - Free Report) , Blue Buffalo Pet Products (BUFF - Free Report) and Energizer Holdings, Inc. (ENR - Free Report) , all carrying a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Inter Parfums increased 22% over the past one year. Further, it posted an average earnings beat of 7.4% in the trailing four quarters.
Blue Buffalo Pet Products has a long-term earnings growth rate of 17.5%. Moreover, it posted an average earnings beat of 6.8% in the trailing four quarters.
Energizer, with a long-term earnings growth rate of 9.8% has surged 29.9% in the past one year.
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
See This Ticker Free >>